Navigation Links
Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs
Date:5/3/2010

MINNEAPOLIS, May 3 /PRNewswire/ -- Rescue Riders, a national volunteer organization dedicated to giving motorcyclists the tools and training necessary to provide emergency medical assistance, has selected the HeartSine® samaritan® PAD Automated External Defibrillator (AED) for use by its members.

Rescue Riders currently has more than 3,000 motorcycle-riding volunteers in 40 states who are trained as first responders for roadside medical emergencies. According to Dean Akey, Founder & President, Rescue Riders, the organization made the samaritan PAD its defibrillator of choice because of its compact size, durability and ease of use. Akey added, "The HeartSine samaritan PAD qualities fit well with first responders traveling via motorcycle."

Unfortunately, the need for this kind of response is well documented. According to U.S. Department of Transportation statistics, motorcyclists are 37 times more likely to die and eight times more likely to be injured in a crash than passenger car occupants, per vehicle mile traveled. This makes an automated external defibrillator a valuable component of a volunteer's set of medical tools.

"A unique aspect of the samaritan PAD," said Gregory Cash, CEO of HeartSine Technologies, Inc. "is that it is designed for use by rescuers of all skill levels. With Sudden Cardiac Arrest, time is critical, and this defibrillator enables a rescuer to perform emergency defibrillation with confidence. The right defibrillator, in the right place, in the right hands, could make the difference between life and death."

About Rescue Riders (http://www.rescueriders.org/)

The Rescue Riders organization recruits, educates and organizes motorcyclists in support of each other, their communities and the country. Currently covering 40 states, the organization provides motorcyclists with the tools and training needed to provide emergency assistance in times of need as Good Samaritans. Additional Information: 630-444-0588.

About HeartSine Technologies (www.heartsine.com)

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of proprietary technologies and quality products. Its HeartSine samaritan PAD is a sophisticated, lightweight automated external defibrillator designed for rescuers of all skill levels and is ideal for sports facilities, schools, churches and all businesses.

Additional information:  info@heartsine.com; (866) 478-7463, ext. 112


'/>"/>
SOURCE HeartSine Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
2. AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study
3. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
4. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
5. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Medical City Hospital Partners With Dallas Fire-Rescue to Outfit First Mobile Units in Dallas County With Advanced EKG Technology
8. New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention
9. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
10. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2017)... Sept. 1, 2017  Bayer will present the latest research ... for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... new preclinical and clinical data on Bayer,s marketed portfolio and ... projects. "We value ... in cancer research at ESMO," said Carsten Brunn , ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
(Date:8/28/2017)... , Aug. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... on Monday, September 11, 2017, in New York ... executive officer, is scheduled to present at 11:05 a.m. Eastern ... accessed at http://ir.hill-rom.com/events.cfm . A recorded replay will be ... through December 10, 2017. ...
Breaking Medicine Technology:
(Date:9/22/2017)... San Diego, CA (PRWEB) , ... September 22, ... ... to offer groceries, wearable, and more products at customers’ doorstep. According to Smart ... Besides, Smart Mart has stated to offer wearable, and customers can find clothing ...
(Date:9/21/2017)... ... September 21, 2017 , ... With ProSlideshow Portrait from Pixel Film Studios ... Users can select from up to two layers of subject matter along with fully ... all within Final Cut Pro X. , With ProSlideshow Portrait each user ...
(Date:9/21/2017)... Chicago, IL (PRWEB) , ... September 21, 2017 , ... ... set to run from September 11 to the end of November. , The Chicago, ... out to their community and teach them about the ease of taking their personal ...
(Date:9/21/2017)... ... September 21, 2017 , ... Hair ... new member survey conducted by the International Society of Hair Restoration Surgery ... to 2016 rose 60 percent, with 635,189 procedures performed in 2016. , ...
(Date:9/21/2017)... ... ... In addition to sticking with the new years goal ... use natural alternatives for all house cleaning products, disinfectants, respiratory relief, and much ... new line of essential oils, are all 100% organic and natural. , Combine ...
Breaking Medicine News(10 mins):